Prevalence of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India

Microbiology and Immunology

Volumn 55, Issue 4, 2011, Pages 239-246

  Karunasagar, Anusha ^a   Maiti, Biswajit ^b   Shekar, Malathi ^b   Shalini Shenoy, M ^a   Karunasagar, Indrani ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b University   (India)

Author keywords

Acinetobacter spp; Carbapenemase; Multiplex pCR; OXA genes

Indexed keywords

BETA LACTAMASE OXA 23; BETA LACTAMASE OXA 24; BETA LACTAMASE OXA 51; BETA LACTAMASE OXA 58; CARBAPENEMASE; MEROPENEM; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DNA FINGERPRINTING; GENE INSERTION SEQUENCE; GENE TARGETING; GENETIC HETEROGENEITY; INDIA; ISABA1 GENE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; RANDOM AMPLIFIED POLYMORPHIC DNA;

ACINETOBACTER; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; GENETIC HETEROGENEITY; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; PHYLOGENY;

ACINETOBACTER; ACINETOBACTER BAUMANNII;

EID: 79953074598     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00313.x     Document Type: Article

References (29)

1. Peleg A.Y., Seifert H., Paterson D.L. (2008) Acinetobacter baumannii: Emergence of a successful pathogen. Clin Microbiol Rev 21: 538-82.
2. Giamarellou H., Antoniado A., Kanellakopoulou K. (2008) Acinetobacter baumannii: a universal threat to public health? Intl J Antimicrob Agents 32: 106-09.
3. Ambler R.P., Coulson A.F., Frere J.M., Ghuysen J.M., Joris B., Forsman M., Levesque R.C., Tiraby G., Waley S.G. (1991) A standard numbering scheme for the class A beta-lactamases. Biochem J 276: 269-270.
4. Bush K., Jacoby G.A., Medeiros A.A. (1995) A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39: 1211-33.
5. Paterson D.L., Bonomo R.A. (2005) Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18: 657-86.
6. Walther-Rasmussen J., Hoiby N. (2006) OXA-type carbapenemases. J Antimicrob Chemother 57: 373-83.
7. OXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44: 2974-6.
8. Dijkshoorn L., Nemec A., Seifert H. (2007) An increasing threat in hospitals: multidrug resistant Acinetobacter baumannii. Nature Rev Microbiol 5: 939-51.
9. Gaur A., Garg A., Prakash P., Anupurba S., Mohapatra T.M. (2008) Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. J Health Popul Nutr 26: 183-8.
10. Uma K.R., Srinivasa R.R., Sahoo S., Shashikala P., Kanungo R., Jayachandran S., Prashanth K. (2009) Phenotypic and genotypic assays for detecting the prevalence of metallo-β-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J Med Microbiol 58: 430-5.
11. Sinha M., Srinivasa H., Macaden R. (2007) Antibiotic resistance profile and extended spectrum β-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 126: 63-7.
12. Lee H.W., Koh Y.M., Kim J., Lee J.C., Lee Y.C., Seol S.Y. Cho D.T., Kim J. (2008) Capacity of multidrug resistant clinical isolates of A. baumannii to form biofilm and to adhere to surfaces. Clin Microbiol Infect 14: 49-54.
13. Bouvet P.J., Grimont P.A. (1987) Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 138: 569-78.
14. CLSI (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement, M100-S20, Vol. 30. Wayne, PA: Clinical and Laboratory Standards Institute.
15. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. (editors) (1995) Short protocols in molecular biology: a compendium of methods from current protocols in molecular biology, 3rd edn. New York: John Wiley and Sons.
16. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., Amyes S.G.B., Livermore D.M. (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27: 351-3.
17. Afzal-Shah M., Woodford N., Livermore D.M. (2001) Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 45: 583-8.
18. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., Pitt T.L. (2006b) The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumanii. FEMS Microbiol Lett 258: 72-77.
19. ABA-1 customized for Acinetobacter? FEMS Microbiol Lett 243: 425-9.
20. Rodriguez-Bano J., Marti S., Soto S., Fernandez-Cuenca F., Cisneros J.M., Pachon J., Pascual A., Martinez-Martinez L., McQueary C., Actis L.A., Vila J. (2008) Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 14: 276-8.
21. Neilan A. (1995) Identification and phylogenetic analysis of toxigenic cyanobacteria by multiplex randomly amplified polymorphic DNA PCR. Appl Environ Microbiol 61: 2286-91.
22. Heritier C., Poirel L., Fournier P.E., Claverie J.M., Raoult D., Nordmann P. (2005) Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 49: 4174-9.
23. Mendes R.E., Bell J.M., Turnidge J.D., Castanheira M., Jones R. N. (2009) Emergence and widespread dissemination of OXA-23, -24/40 and-58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance programme. J Antimicrob Chemother 63: 55-9.
24. Figueiredo S., Poirel L., Papa A., Koulourida V., Nordmann P. (2009) Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9. Antimicrob Agents Chemother 53: 4045-57.
25. Bogaerts P., Cuzon G., Naas T., Bauraing C., Deplano A., Lissoir B., Nordmann P., Glupczynski Y. (2008) Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium. Antimicrob Agents Chemother 52: 4205-6.
26. Mussi M.A., Limansky A.S., Viale A.M. (2005) Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins. Antimicrob Agents Chemother 49: 1432-40.
27. Fernandez-Cuenca F., Martinez-Martinez L., Conejo M.C., Ayala J.A., Perea E.J., Pascual A. (2003) Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 51: 565-74.
28. Graser Y., Klare I., Halle E., Gantenberg R., Buchholz P., Jacobi H.D., Presber W., Schönian G. (1993) Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting. J Clin Microbiol 31: 2417-20.
29. Sechi L.A., Karadenizli A., Derruí A. (2004) PER-1 type β-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit 10: CR180-4.